YS-49
YS-49 is a PI3K/Akt (a downstream target of RhoA) activator, to reduce RhoA/PTEN activation in the 3-methylcholanthrene-treated cells. YS-49 inhibits angiotensin II (Ang II) -stimulated proliferation of VSMCs via induction of heme oxygenase (HO) -1. YS-49 is also an isoquinoline compound alkaloid, has a strong positive inotropic action through activation of cardiac β-adrenoceptors[1][2][3].
Product Specifications
CAS Number
132836-42-1
UNSPSC
12352005
Hazard Statement
H302
Target
Adrenergic Receptor; Akt; Angiotensin Receptor; PI3K
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling; PI3K/Akt/mTOR
Applications
COVID-19-immunoregulation
Field of Research
Cardiovascular Disease; Endocrinology
Assay Protocol
https://www.medchemexpress.com/ys-49.html
Purity
99.98
Solubility
DMSO : 100 mg/mL (ultrasonic) |H2O : 10 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
OC1=CC2=C(C(CC3=C4C=CC=CC4=CC=C3)NCC2)C=C1O.[H]Br
Molecular Formula
C20H20BrNO2
Molecular Weight
386.28
Precautions
H302
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, stored under nitrogen)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Major Vault Protein (MVP) (1032), CF568 conjugate, 0.1mg/mL
Cytokeratin, HMW (KRTH/1076), CF405S conjugate, 0.1mg/mL
HPV-16 (Human Papilloma Virus 16) (rHPV16L1/1058), CF594 conjugate, 0.1mg/mL
